Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
OBJECTIVE: Long-standing evidence indicates that Alzheimer's disease patients with behavioral symptoms have a worse prognosis and a more rapid disease progression. The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer�...
Үндсэн зохиолчид: | Wilcock, G, Ballard, C, Cooper, J, Loft, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2008
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
-н: Wilcock, G, зэрэг
Хэвлэсэн: (2006) -
Donepezil and memantine for moderate-to-severe Alzheimer's disease
-н: Howard, R, зэрэг
Хэвлэсэн: (2012) -
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
-н: Jones, R, зэрэг
Хэвлэсэн: (2009) -
The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
-н: Wilcock, G
Хэвлэсэн: (2007) -
Donepezil for the treatment of agitation in Alzheimer's disease.
-н: Howard, R, зэрэг
Хэвлэсэн: (2007)